A clinical and genotype-phenotype analysis of MACF1 variants
- PMID: 40925378
- PMCID: PMC12431674
- DOI: 10.1016/j.ajhg.2025.08.010
A clinical and genotype-phenotype analysis of MACF1 variants
Abstract
Microtubule-actin cross-linking factor 1 (MACF1) is a large protein of the spectraplakin family, which is essential for brain development. MACF1 interacts with microtubules through the growth arrest-specific 2 (Gas2)-related (GAR) domain. Heterozygous MACF1 missense variants affecting the zinc-binding residues in this domain result in a distinctive cortical and brain stem malformation. Evidence for other MACF1-associated disorders is still limited. Here, we present a cohort of 45 individuals with heterozygous or bi-allelic MACF1 variants to explore the phenotypic spectrum and assess possible pathogenic relevance. We observe that de novo heterozygous missense variants in the EF-hand domains also result in distinctive brain malformation and provide experimental evidence that variants in the EF-hand/GAR module increase microtubule binding, suggestive of a toxic gain of function. Notably, no phenotype-genotype correlation was possible for the remaining heterozygous variants in other domains. A clinical review of eight families with bi-allelic variants reveals a possible complex neurodevelopmental syndrome of the central and peripheral nervous systems. In these individuals, bi-allelic variants mostly affect the Plakin domain. Furthermore, RNA sequencing and chromatin immunoprecipitation (ChIP) analyses of human fetal brain tissue reveal five MACF1 isoforms with region-specific expression, differing in their exon 1 transcription start sites but splicing to a common exon 2. This differential expression explains the frontal-predominant lissencephaly in an individual with a homozygous stop-gain in exon 1 (MACF1-204: c.70C>T [p.Arg24∗]), as this isoform is preferentially expressed in the frontal cortex. We conclude that MACF1-related disorders are strictly linked to domain function and the level of transcript expression, explaining the observed wide clinical heterogeneity.
Keywords: ACF7; MACF1; axonal pathfinding; brainstem hypoplasia; lissencephaly; microtubules.
Copyright © 2025 American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors declare no competing interests.
References
-
- Stanley JR, Hawley-Nelson P, Yuspa SH, Shevach EM, and Katz SI (1981). Characterization of bullous pemphigoid antigen: a unique basement membrane protein of stratified squamous epithelia. Cell 24, 897–903. - PubMed
-
- Byers TJ, Beggs AH, McNally EM, and Kunkel LM (1995). Novel actin crosslinker superfamily member identified by a two step degenerate PCR procedure. FEBS Lett 368, 500–504. - PubMed
-
- Yang Y, Dowling J, Yu QC, Kouklis P, Cleveland DW, and Fuchs E (1996). An essential cytoskeletal linker protein connecting actin microfilaments to intermediate filaments. Cell 86, 655–665. - PubMed
-
- Feng Y, and Walsh CA (2001). Protein-protein interactions, cytoskeletal regulation and neuronal migration. Nat Rev Neurosci 2, 408–416. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources